Trial Profile
A Study Asessing Pneumococcal Carriage Rates in Healthy Infants after the Introduction of PCV13 in Hong Kong
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics; Therapeutic Use
- 12 Jan 2018 New trial record